(Q48333373)

10 February 2018

title

Inflammatory molecule release by beta-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol. (English)

1 reference

10 February 2018

1 reference

Landolfi C

1

1 reference

10 February 2018

Soldo L

2

1 reference

10 February 2018

Polenzani L

3

1 reference

10 February 2018

Apicella C

4

1 reference

10 February 2018

Capezzone de Joannon A

5

1 reference

10 February 2018

Coletta I

6

1 reference

10 February 2018

Di Cesare F

7

1 reference

10 February 2018

Brufani M

8

1 reference

10 February 2018

Pinza M

9

1 reference

10 February 2018

Milanese C

10

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

10 February 2018

European Journal of Pharmacology

published in

1 reference

10 February 2018

volume

360

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

55-64

1 reference

10 February 2018

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Interleukin-1 and tumor necrosis factor-mediated regulation of C3 gene expression in human astroglioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Prostaglandins stimulate calcium-dependent glutamate release in astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Regulation of the release of interleukin-6 from human astrocytoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

"In vitro" effect of interleukin-1 beta on human glioma cell lines: regulation of cell proliferation and IL-6 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Paracetamol and phenacetin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Production of superoxide anions by a CNS macrophage, the microglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

beta-Amyloid neurotoxicity: a discussion of in vitro findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Inflammatory mechanisms in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Estimation of the in vivo effect of cyclooxygenase inhibitors on prostaglandin E2 levels in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Pharmacology of free radicals; recent views on their relation to inflammatory mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Amyloid plaque core protein in Alzheimer disease and Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Anti-inflammatory drugs and Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Kinetics and metabolism of paracetamol and phenacetin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

New perspectives on Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Clinical trial of indomethacin in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Risk of Alzheimer's disease and duration of NSAID use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Characterisation of cyclooxygenase 1 and 2 expression in mouse resident peritoneal macrophages in vitro; interactions of non steroidal anti-inflammatory drugs with COX2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Complement gene expression in neuroblastoma and astrocytoma cell lines of human origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Control of the expression of a class II major histocompatibility gene (HLA-DR) in various human cell types: down-regulation by IL-1 but not by IL-6, prostaglandin E2, or glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900663-3

10.1016/S0014-2999(98)00663-3

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9845273

1 reference

10 February 2018